News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
13,066 Results
Type
Article (554)
Company Profile (1)
Press Release (12511)
Section
Business (3412)
Career Advice (1)
Deals (827)
Drug Development (1147)
Employer Resources (1)
FDA (245)
Job Trends (118)
News (5757)
Policy (498)
Tag
Academia (18)
Alliances (1597)
ALS (1)
Alzheimer's disease (8)
Antibody-drug conjugate (ADC) (2)
Approvals (252)
Artificial intelligence (4)
Autoimmune disease (2)
Best Places to Work (90)
Biosimilars (7)
Bladder cancer (2)
Breast cancer (10)
Cancer (48)
Cardiovascular disease (2)
Career advice (1)
CAR-T (1)
Cell therapy (8)
Clinical research (1024)
Collaboration (38)
Compensation (10)
COVID-19 (37)
CRISPR (1)
C-suite (12)
Cystic fibrosis (1)
Data (70)
Depression (1)
Diabetes (3)
Diagnostics (127)
Drug discovery (2)
Drug shortages (1)
Earnings (872)
Employer resources (1)
Events (1129)
Executive appointments (8)
FDA (285)
Funding (18)
Gene editing (2)
Gene therapy (6)
GLP-1 (10)
Government (27)
Guidances (5)
Healthcare (305)
IgA nephropathy (1)
Immunology and inflammation (3)
Indications (2)
Infectious disease (37)
Intellectual property (5)
Interviews (1)
IPO (206)
Job creations (31)
Job search strategy (1)
Layoffs (1)
Legal (148)
Liver cancer (1)
Lung cancer (4)
Lymphoma (1)
Management (1)
Manufacturing (14)
Medical device (183)
Medtech (184)
Mergers & acquisitions (639)
Metabolic disorders (4)
Multiple sclerosis (4)
Neuropsychiatric disorders (1)
Neuroscience (18)
NextGen: Class of 2026 (43)
Non-profit (4)
Obesity (1)
Pain (8)
Pancreatic cancer (1)
Parkinson's disease (1)
Patents (5)
Patient recruitment (8)
People (813)
Pharmaceutical (1)
Phase 1 (316)
Phase 2 (443)
Phase 3 (358)
Pipeline (60)
Postmarket research (41)
Preclinical (108)
Prostate cancer (3)
Radiopharmaceuticals (6)
Rare diseases (8)
Real estate (127)
Regulatory (379)
Reports (1)
Research institute (23)
Series A (6)
Service/supplier (1)
Startups (85)
Supply chain (1)
Vaccines (4)
Date
Last 7 days (3)
Last 30 days (28)
Last 365 days (338)
2026 (31)
2025 (334)
2024 (452)
2023 (554)
2022 (1826)
2021 (1631)
2020 (1119)
2019 (751)
2018 (473)
2017 (641)
2016 (518)
2015 (744)
2014 (579)
2013 (492)
2012 (564)
2011 (503)
2010 (429)
Location
Africa (6)
Arizona (1)
Asia (591)
Australia (174)
California (59)
Canada (34)
China (3)
Delaware (6)
Europe (5359)
Florida (8)
Georgia (2)
Idaho (1)
Illinois (15)
Indiana (1)
Japan (15)
Maryland (6)
Massachusetts (66)
Michigan (9)
New Jersey (27)
New York (9)
North Carolina (9)
Northern California (43)
Pennsylvania (78)
South America (17)
Southern California (8)
Texas (4)
United States (306)
Utah (7)
Washington State (1)
Wisconsin (1)
13,066 Results for "indivumed gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Indivumed and University of Rochester Medical Center expand collaboration for patient-centric discovery of novel therapeutics
December 10, 2025
·
4 min read
Press Releases
Croma-Pharma GmbH Enters Strategic Distribution Partnership with Renellence in Canada
October 10, 2025
·
2 min read
Press Releases
IBA integrates Artificial Intelligence Quality Assurance into dosimetry solutions through the acquisition of PhantomX GmbH
November 3, 2025
·
2 min read
Indivumed Evolves into Indivumed Therapeutics to Focus on Data and AI-Driven Advancement of Precision Oncology
After twenty years as one of the first personalized oncology companies, Indivumed announced its evolution into Indivumed Therapeutics after the acquisition of Indivumed Services GmbH and its CRO service offerings by Crown Bioscience.
April 4, 2023
·
3 min read
Indivumed Services’ Hamburg Site Receives College of American Pathologists (CAP) Accreditation
Indivumed Services GmbH, a Crown Bioscience company, announced that its Hamburg site received laboratory accreditation from the College of American Pathologists.
September 11, 2023
·
3 min read
Deals
Crown Bioscience Announces Transaction Closing of Indivumed’s Service Business and Supporting Biobank
Crown Bioscience, a global contract research organization and JSR Life Sciences company, announced that it has completed its acquisition of the IndivuServ business unit of Indivumed GmbH on March 31, 2023.
April 4, 2023
·
3 min read
Deals
Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank
Crown Bioscience , a global contract research organization (CRO) and a JSR Life Sciences company, has announced it has entered into an agreement to acquire the IndivuServ business unit of Indivumed GmbH.
January 25, 2023
·
5 min read
Press Releases
Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody
November 5, 2025
·
3 min read
Press Releases
PEPperPRINT GmbH launches cLIFT technology for next-generation peptide microarrays
June 10, 2025
·
3 min read
Press Releases
Crescita Therapeutics Announces Mutual Termination of Licensing Agreement with Croma Pharma GmbH for Pliaglis®
May 23, 2025
·
7 min read
1 of 1,307
Next
